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1PREFACE
This report summarizes the activities of the NASA Biomedical Applications
Team program at Stanford University for the period from October 1, 1975 through
September 30, 1976. This program is under the direction of Donald C. Harrison,
M.D., Chief of the Division of Cardiology at the Stanford University School of
Medicine. The Stanford Biomedical Applications Team program is supported under
NASA Grant No. NGR 05-020-634 and its technical monitor is Harold Sandler, M.D.,
Chief of the Biomedical Research Division at the NASA-Ames Research Center.
For the convenience of the reader the names and addresses of medical device
manufactures referred to in this report are included in Appendix B. This listing
does not constitute an endorsement by either the National Aeronautics and Space
Administration or the Stanford University School of Medicine.
2ABSTRACT
This report covers the major efforts of the Stanford Biomedical Applications
Team Program at the Stanford University School of Medicine for the period from
October 1, 1975 to September 31, 1976. This program is supported under NASA
Grant, NASA NGR-05-020-634 and its technical monitor is Harold Sandler, M.D.,
Chief of the Biomedical Research Division, at the nearby NASA-Ames Research
Center. The director of this program is Donald C. Harrison, Chief of the Division
of Cardiology of the Stanford University School of Medicine. During this re-
porting period, the Stanford BATeam, with the help of scientists and engineers
at the Ames-Research Center, had made significant progress on a variety of
aerospace technology projects.
A completed EMG Biotelemetry System has been delivered to the Children's
Hospital at Stanford. This wide-band multi-channel patient monitoring instru-
ment represents an adaptation of NASA experience in the field of biotelemetry
in monitoring the physiological signals of man and animals in space related re-
search.
During this reporting period, the Third International Symposium on
1
Biotelemetry was held May 17-20, 1976 at Pacific Grove, California. Sponsored
by the NASA-Ames Research Center, The Stanford University School of Medicine
and the Jet Propulsion Laboratory, this international conference provided a
forum for the dissemination of recent advances made by NASA in the field of
physiological monitoring. Also completed during this reporting period has been
the editing of the text Biotelemetry III.This publication of the proceedings of
the Third International Symposium on Biotelemetry will be-released in December,
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1976 through Academic Press.
In order to illustrate the function of the Biomedical Applications	 -.
Program the film, "Dividends From Space - Biomedical Applications of Aerospace
Technology" has been completed. This color motion picture shows nurses, tech-
nicians, doctors, patients and aerospace engineers working together to bring
the advances of the space program to the patient. This film is now available
for showing at engineering and medical meetings as well as to the general public.
The results of a pilot study involving lower body negative pressure testing
in cardiac patients has been completed as well as the design and construction of
i
a new,,leg negative pressure unit for evaluating heart patients at Stanford Universit .
I
This technology is based on NASA research, using vacuum chambers to stress the
cardiovascular system during space flight.
Additional laboratory tests of an intracranial pressure transducer, (based
on a pressure cell originally developed by NASA for wind tunnel tests of aircrafts)
have been conducted. Extremely stable long term data using capacative pressure
sensors has lead to the order of commerciajly manufactured monitoring systems based
on the NASA design.
Projects involving commercialization are. Flexible medical electrodes,
NASA echocardioscope, a miniature biotelemetry system, and an on-line ventricular
contour detector. Each of these is in various stages of commercial development,
including a presently marketed device (the flexible medical electrode) and a NASA
developed system just recently disclosed to manufacturers (the-on-1ine ventricular
contour detector).
In addition to these on-going and completed projects, t
	 Stanford BATeam
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has identified three new biomedical problems to which NASA technology is
applicable. These are: A communication device for the speech impaired, the
NASA developed liquid-cooled garment and . min.iature force transducers for
heart research. This re port is concluded with a bibliography of p 0lications
which were the direct result of BATeam projects and is followed by a listing
of medical device manufacturers who are involved in the commercialization of
NASA technology transferred by the Stanford BATeam.
INTRODUCTION
I
5THE BIOMEDICAL APPLICATIONS TEAM CONCEPT
The Technology Utilization Program
Biomedical Applications Teams represent an important element in the	 -^
overall NASA Technology Utilization Program. The Technology Utilization Program,
began in 1962,and was established for the following purposes:
1. To increase the return on the national investment in aeronautical
and space programs by helping to bring about additional uses of the
knowledge gained in these programs.
2. To shorten the time from the development of new knowledge to its
effective utilization.
3. To aid the movement of new knowledge across organizational, disciplinary,
and regional boundaries.
4.. To help develop better methods for communicating and applying govern-
ment generated knowledge to private industry.
The Biomedical Applications Teams'
Biomedical Applications Teams (BATeams) were established by NASA in 1966 for
3
the specific purpose of transferring aerospace technology to the solution of
I
biomedical problems. Basically, the BATeam acts as an interface between medical
researchers and NASA engineers. Team members meet with investigators in the
i
medical and biological sciences to define significant technological problems.
i
Only those problems are considered which meet the following criteria:
1. No ready solution is available through commercial medical instru-
ment manufacturers.
	 i
2. The problem can be defined in such terms that an aerospace related
technology could be applicable to a solution.
3. Solution of the problem would make a significant contribution to
medical research or clinical medical practice.
There are four Biomedical Applications Teams established at the following
institutions:
6Stanford University School of Medicine
Cardiology Division
Biomedical Technology Transfer
701 Welch Road - Suite 3303
Palo Alto, California 94303
Research Triangle Institute
P.O. Box 12194
Research Triange Park
North Carolina 27709
Advisory Center for Medical Technology and Systems
University of Wisconsin
1500 Johnson Drive
Madison, Wisconsin 53706
Martin Marietta
Mail Code DE5
Lyndon B. Johnson Space Center
Houston, Texas 77058
Technology Transfer Process
There are many different ways in which technology developed through the
space program can be applied or transferred to solving biomedical problems. The
term technology itself is very broad including both hardware and software as
well as the engineering expertise that has been apart of .aerospace pro-
jects. No single approach to transferring technology to medicine is applicable
to all medical problems. The approach must be adapted to the particular problem
and the institutions that are involved. However, the general procedure followed
by all the B iomedical Applications Teams is as follows:
First a BATeam member confers with the problem originator. Clarification
of technological aspects of the problem leads to the formulation of a "Problem
Statement". Besides defining the problem in greater detail, the Problem State-
ment answers the following questions:.
1. What medical specialty is involved?
i	
2. How has this problem been solved in the past?
Ln
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3. What presently available commercial equipment is applicable?
4. What broad-based medical impact will solution of the problem
have?
5. Could the technological solution offered by NASA be readily
made commercially available.
Answering these questions frequently requires the use of both computerized
searching, utilizing NASA data banks, and direct contact with scientific and
engineering staff at the NASA field centers. Circulation of problem state-
ments among NASA scientists and engineers frequently results in unexpected and
novel approaches. Finding that a solution does exist within the NASA program,
the process of technology transfer has just begun.
If after careful screening a problem is found to be of sufficient medical
significance and to have a potential NASA technological solution, the BATeam then
attempts to implement or transfer this aero-space solution to the medical field,
Instrumentation originally designed for the space program can seldom be
directly applied to a biomedical problem. Usually the medical problem originator
needs assistance in implementing the NASA technology. A NASA instrument may
require adaptive engineering or redesign of its capabilities before its
feasibility in solving a medical problem can be demonstrated. This problem
of adaptive engineering is a significant one and frequently requires the
material as well as engineering resources of a NASA field center or medical
device menufacturer. The prototype device must then be clinically tested to
determine that it meets specified engineering and medical standards.
^	 4	 I
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One of the more recent goals of the Biomedical Applications Team Program
is to increase the availability of the NASA solutions through commercialization.
After a biomedical problem has been screened and a unique NASA technological
solution has been found, the use of this technology by other medical investi-
gators and institutions must be considered. If the original problem has been
carefully selected, there will be medical device manufacturers interested in
the NASA solution. There are many criteria which enter into the decision as to
whether or not medical device manufacturers will accept the new idea. Certainly
profitability and the results of market studies are important considerations.
If a company is interested in the innovation, NASA can then grant the company a
license to manufacture and sell the device.
Commercialization, though an important objective in technology transfer,
is only one facet of the BATeam program. If NASA engineering expertise can
help an investigator make a significant contribution to medical research, an
important transfer will have occurred even though it has not resulted in a
marketable product.
The Stanford Biomedical Applications Team
The Stanford Biomedical Applications School is a nationally recognized
authority in the medical speciality of Cardiology. The Stanford University
BATeam functions within the Division of Cardiology and has emphasized solving
urgent problems related to the heart. Previous applications of aerospace
technology to this medical speciality have included projects in electrocardi-
ography, cardiac catherization, biomedical electrodes, and ultrasound imaging
of the heart. Although emphasizing Cardiology, the Stanford BATeam has found
-LI,
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new applications for space technology in such diverse areas as Cerebral Palsy,
Neurisurgery, Orthopedics and Internal Medicine.
The Stanford BATeam is a multi-disciplinary group of scientists, doctors,
and engineers. The principal members of this team are:
Donald C. Harrison, M.D.
Chief of Cardiology and Biomedical
Applications Team Director
Gene Schmidt, M.D.
Assistant Director
Harry Miller
Deputy Director
Edwin Carlson, M.D.
Cardiovascular Research Associate
Richard Popp, M.D.
Assistant Professor of Cardiology
Earceal Kidd
Program Secretary and Special
Projects Coordinator
Robert J. Debs
Manley Hood
Paul Purser
(Part-time eng
These team members at Stanford Universit,
at the nearby NASA-Ames Research Center
other NASA Field Centers (see map).
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'NASA-Ames Res. Ctr. *..Denver Res. Inst.
tanford University
Midwest Res. I Inst.
JPL
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Lewis'Res. Ctr.
oddard Space F1t.Ct•-.
ASA Headquarters
Langley Res_ Ctr.
o x earch Triangle Inst. j
Manned Space Flight Ctr.
Sohwhwes Ike'. Inst.
Location of NASA Field Centers and Applicaticn Teams
Personnel at the NASA-Ames Research Center who have been involved in BATeam
projects during this reporting period are:
Harold Sandler, M.D. Chief,
Biomedical Research Division
Walter Goldenrath, Ames-Wesrac,
Technical Coordinator
Robert Zimmerman, Bioengineering
Consultant
Charles Kubokawa, Technology
Utilization Officer
Robert Lee, Electronic
Instrument Development Branch
Salvadore Rositano, Electronic
Systems Engineering Branch
Richard Westbrook, Electronic
Systems Engineering Branch
do. #
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Ernest McCutcheon, M.D.
Biomedical Research Division 	 f
Thomas Fryer, Assistant Chief
Electronic Instrument Development Branch
The spirit of cooperation and free exchange of ideas between the Stanford BATeam
and the NASA Field Centers provides the unique breadth and depth of experience
needed for identifying and implementing solutions to biomedical problems.
i
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PROJECTS
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EMG TELEMETRY IN CEREBRAL PALSY
OBJECTIVES	 -
To utilize NASA engineering expertise in the field of miniature biotelemetry
	 .^.
to provide a better method for monitoring the gait of children with cerebral
palsy.
BACKGROUND
Children with cerebral palsy have neurological defects which severely retard
their walking ability. They are frequently handicapped by spastic muscles which
are in a state of constant contraction making ambulation awkward and difficult.
Determining precisely which muscle groups are contributing to the child's walking
difficulty is a complex problem requiring the combined talents of orthopedists
and physical therapists. Direct diagnosis of the child's handicap is extremely
important because there are orthopedic operations (involving tendon and muscle
lengthening) which can be used to improve the child's gait.
As an aid to more accurate diagnosis, physical therapists.have employed the
electromyogram (EMG) to determine whether muscle groups are spastic or normal.
This approach has required the use of cables extending from the child to a re-
cording instrument. The cables necessarily encumbured the child and caused him
to modify his walking pattern thereby creating inaccuracies in the record.
Two years ago NASA engineers provided assistance in implementing a waist
belt transmitter system to telemeter the EMG signal and allow 	 the child greater
freedom of motion. As he walked in his normal way, the EMG signal of individual
1
56
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muscle groups within the legs were continuously transmitted, received and
recorded. This approach, using biotelemetry, proved to be extremely useful in
making over one hundred and fifty evaluations in the gait analysis laboratory
at Stanford Children's Hospital. Analysis of these data was useful in three major
areas: 1) Evaluating gait changes before and after tendon and muscle
lengthening (Ref. 1) 2) Evaluation of the effect of a new muscle relaxing drug
in reducing spasticity (Ref. 2) 3) Analysis of the effects of different types
of braces. Although this approach was promising, it had certain major limi-
tations (Ref. 3).
As shown in Figure 1, the original telemetry approach allowed for recording
.of data from only one leg at a time. Seconds adjusting and securing the wires
which ran from the waist-belt transmitter to the sensing electrode over the
	
	
a
•i'
muscle groups proved to be very time consuming. Third, in smaller children and 	 j
in those whose gaits were very unstable, even the three and a half pound weight
of this transmitter was cumbersome and had a detectable effect on the child's j
normal walking pattern. Fourth,.if the child fell and the waist transmitter
or one of the wire connectors became damaged, the entire system was unuseable
	 -
until repairs could be made. This was particularly unfortunate because the
children examined and treated at Stanford Children's Hospital frequently would
have to travel long distances to come back for reevaluation.
14
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Fig. 1
Child with cerebral palsy wearing
prototype waist-belt transmitter.
APPROACH
To resolve these difficulties NASA-Ames Research Center engineers have
developed a broad band, crystal-controlled, miniaturized transmitter (Ref. 4).
It is housed in a one inch diameter by 3/4 inch thick package which is decorated
to make it more acceptable to the young child (Fig. 2).
4_
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Fig. 2
Close-up of miniature EMG transmitter,
Adhesive discs are used to fasten the miniature transmitters to the leg of the
child. Electrodes attached directly to the miniature transmitter pick up the
electrical activity of the underlying muscle groups. The EMG signal is transmitted
using a technique known as differential pulse-width modulation (DPWM). Each
transmitter or "lady bug" contains two silver oxide batteries and employs a
crystal in the emitter which is matched with a second crystal in the receiver
(not shown). Use of matched crystals eliminates tuning difficulties and makes
this system easy to use by non-engineering medical personnel. An additional 	
I
transmitter is employed to transmit foot contact information so that the weight
bearing and swing phases of gait can be correlated with muscle activity. As
shown in fig. 3 below, the new approach eliminates both the cumbersome waist-
belt package and the tangle of cables which are required in the earlier approach
(^ lg	 1)
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Fig. 3
Cerebral palsy patient instrumented
with NASA-designed EMG transmitters.`
PROGRESS
At the time of this report the new miniaturized biotelemetry system has
been delivered to the Stanford Children's Hospital. Fabrication of the lady
bug transmitters based on the NASA-Ames design was completed by the L&M Electronics
Company, Daly City, California. In addition they designed a new wide band re-
ceiver. This completed system has been checked out and antennas have been in-
stalled in the gait analysis laboratory at Children's Hospital to eliminate any
problem with signal drop-out during monitoring. Also during this reporting period,
presentations and publications describing this gait analysis biotelemetry system
have been completed (Ref. 31 4)•
f i
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PLANS
Although the original goal of providing a miniature biotelemetry system
for analyzing the gait of small children with cerebral palsy has been achieved,
some small additional electronic components are needed before this system can be
used routinely in the day-to-day clinical evaluation of patients. The Stanford
	
ri...
Biomedical Applications Team is providing some additional support in the form
of an analogue to digital converter for the foot switch information and a, signal
calibrator to allow use of an existing strip chart recorder. These additional
tasks are minor and should be completed within one month.
Once fully operational, this system will be used in the daily evaluation of
children with gait abnormalities. Clinicians at Stanford Children's Hospital
will be evaluating large numbers of patients referred from the north western re-
gion of the United States. This equipment will be used in direct patient care
activities as well as in research programs. The Stanford BATeam has already
received requests from other institutions treating handicapped children for the
loan or purchase of a similiar system. We anticipate that additional requests
will be received and that these orders will be filled by the L&M Electronics
Company. Once commercially available to other institutions the process of trans-
ferring the NASA technology which made this project possible will be completed.
PERSONNEL:
Gene Schmidt, M.D.
	
BATeam Coordinator
Thomas Fryer	 }
Salvador Rositano	 )	 NASA-Ames Research Center Engineers
Richard Westbrook	 )
Problem Originators:
Fran Ford, Research Physical Therapist
Eugene E. Bleck, M.D., Chief of Orthopedics and
Rehabilitation, Children's Hospital at Stanford.
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THIRD INTERNATIONAL SYMPOSIUM ON BIOTELEMETRY
There are many ways in which aerospace technology can be transferred to
the solution of problems in biology and medicine. Sometimes this transfer process
involves the fabrication of a medical instrument based upon a design developed
within the space program. More frequently, however, the technology is in the
form of software, i.e., new knowledge and information resulting from basic and
applied research conducted at the NASA field centers. In order to make industry
and university groups more aware of NASA technological advances, the Stanford
University Biomedical Applications Team has periodically conducted major (frequently
international) conferences on a variety of specific technological subjects.
Previous conferences have included:
1. Biomedical Electrode Technolcgy - Theory and Practice;
Stanford University; September, 1973.
2. Cardiovascular Imaging and Image Processing: Ultrasound,
Angiography and Isotopes; Stanford University, July, 1975.
NASA is one of the largest developers and users of biotelemetry in the
world because of the need for remote monitoring of physiological signals in man
w'
and animals during space flight. Consequently, NASA has taken the lead in sponsoring
the Third International Symposium on Biotelemetry. As in previous conferences,
the Stanford BATeam provided origanizational, secretarial, and technical
support.
More than two hundred scientists, engineers and -physicians attended
the 3rd International Conference on Biotelemetry held May 17-20 in Pacific Grove,
California. This conference was sponsored by the Technology Utilization office
at NASA-Ames Research Center, the Stanford University Division of Cardiology,
pµ	 and the International Society on Biotelemetry.
ft
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There were 82 speakers presenting papers in the following
1. Human"Research Applications
2. Implantable Telemetry Systems
3. Patient Monitoring and Clinical Telemetry
4. Neurological Applications
5. Measurements From Unrestrained Animals
6. Transducers for Biotelemetry
7. Biomedical Telemetric Equipment
Dr. Harold Sandler, Chief of the Biomedical Research Division
Research Center, gave the keynote address entitled "Biotelemetry: l
50 Years". Dr. Normal H. Holter, President of Holter Research Four,u-„, ­ ,
and one of the pioneers of Biotelemetry spoke at a special evening session on
"The Genesis of Biotelemetry".
Registrants and speakers included scientists, physicians, and engineers
from the following countries: Sweden, Italy, Denmark, New Zealand, West Germany,
United Kingdom, France, East Germany, Canada, The Netherlands, USSR, Japan,
Switzerland, and the United States. Many of these speakers and attendees are
well known international leaders in their respective fields.
Following the conference, 40 of the foreign guests returned to	 -
Palo Alto for tours of the Stanford University Cardiology Division, the Integrated
Circuits Laboratory, Fairchild Corporation, and the NASA-Ames Research Center.
The proceedings of the conference will be edited and puk1;^"^A k- "^°A^^;^
Press in December, 1976.
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CLINICAL EVALUATION OF LOWER BODY NEGATIVE PRESSURE (LBNP)
OBJECTIVE
To evaluate lower body negative pressure (LBNP) as a stress test for
measuring the left ventricular function of patients with cardiac disease.
B CKGROUND
Heart disease is responsible for the deaths of more than 750,000 people
each year, and is the leading cause of death in the United States. Cardiologists
}	 have developed many tests to evaluate coronary artery disease. One of the com-
monly used cardiac stress tests is the treadmill ECG in which a patient walks on
a treadmill while his electrocardiogram is recorded and observed for signs of
decreased coronary blood flow. Although this test provides important information
on the state of coronary circulation durin g, physical exercise	 it does not give
complete information on the heart's ability to function as a pump.
At present, cardiologists evaluate the function of.the left ventricle
(the major pumping chamber of the heart) by examining cine-angiograms (X-ray
motion pictures of the heart) taken during cardiac catherization. Cardi?c
catherization requires the passage of a flexible tube or catheter through a
major blood vessel until it reaches the heart. Radio opague, dye is injected
into the heart and the ensuing ejection of the dye from the heart is recorded
on X-ray film. An estimation of the pumping capacity and contractility of the
heart is then made from the X-ray motion picture study.
This procedure is uncomfortable for the patient, time-consuming, expensive,
and involves certain risks. An alternative, non-invasive approach to measuring
-6„
do—
TI
NI
r	 II
^	 I
I
t
6
#.j
21
,
left ventricular function would provide a very useful test for evaluating
cardiac patients (Ref. 5).
Lower body negative pressure testing requires placing the lower half of the
body in a vacuum chamber (see fig. 1 below).
—	 s
Fig. 1	
1
Patient entering LBNP chamber. Adjustable
waist-seal about to be secured.
With waist-seal in place, the chamber is then evacuated in stages. As the pre-
ssure within the LBNP unit is lowered some of the normally circulating blood is
pulled down into the legs and pelvis. The amount of this poo l i;19+depends on the
	 I
pressure level or suction.
i
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Pooling of blood in the lower body causes less blood to be returned to 	 i
the heart. In response to receiving less venous blood, the heart beats	 -
faster and contracts more vigorously, in an attempt to maintain previous cardiac
output and blood pressure. In essence, the LBNP test provides a means for
observing the cardiac response to decrease in venous return.
During an LBNP test the heart rate, electrocardiogram, and cardiac dimensions
(determined using echocardiography) can be monitored non-invasively. This test,
therefore,,holds promise for providing a totally non-invasive method of determing
left ventricular function (Ref. @ The non-invasive measurement of blood pressure
and heart volume would allow the cardiologist to determine ventricular function
curves periodically to help document the improvement or worsening of a patient's
condition.
NASA TECHNOLOGY
LBNP was used extensively in the space program to evaluate the cardiovascular
system of astronauts. As long duration space flights became more common, the
time dependent deconditioning effects of weightlessness became increasingly ap-
parent. Flights as brief as three days caused some astronauts to faint on
return	 to earth and standing up against the full force of gravity. In order
to study the cardiovascular changes occurring during zero gravity, LBNP chambers
were used in the.pre and post-flight evaluation of Applo astronauts and for in-
flight evaluations aboard Skylab (Fig. 2). Richard Popp, M.D., Stanford Cardiologist,
participated in LBNP testing during long term bedrest studies at the NASA-Ames
Research Center. This experience with normal young volunteers has made it now
feasible to extend this technology to evaluate older normal subjects and
cardiac patients.
i^
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Fig. 2
SKYLAB LBNP DEVICE
PROGRESS
During this reporting period the following tasks have been completed:
1	 Data from LBNP tests on older normal subjects and patients
with documented coronary disease were evaluated. A total
of 34 LBNP tests on 17 different individuals were involved.
2. A Cardiology research conference was held at Stanford University
to review these studies and plan future patient protocols involving
LBNP (a summary of this meeting was presented in April/June 1976
Quarterly Report),v
3. A leg negative pressure unit (LNP) was borrowed from Dr. Roger
W'olthius and Robert Johnson at the Johnson Space Center in
Houston, Texas (See Fig. 3). This unit was evaluated using both
echocardiography and impedance plethysmography and showed that
LNP was sufficient to cause significant changes in cardiac volume.
4. Design and construction of a plexiglass leg negative pressure unit
has been completed and is being tested prior to use in the cardiac
catherization laboratory.
24
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Leg Negative Pressure Unit
borrowed from the Johnson
Space Center.
l^ PLANS
The recently completed plexiglass leg negative pressure unit based on the
a
unit loaned to us by the Johnson Space Center is being equipped for validation
studies in the cardiac catherization laboratory at Stanford. Before actual
{{
patient trials are begin, this unit will be checked out in trial runs involving
t.
normal volunteers at the Cardiac Rehabilitation Laboratory.
The cath lab protocol will initially involve approximately 20 patients with
coronary artery disease. After initial hemodynamic studies, these patients will
be subjected to increasing stages of leg negative pressure. Levels of suction
(	 sufficient to cause changes in the left ventricular end diastolic volume will be
t.
a pplied. Measurement of cardiac output and cardiac pressures will be accomplished
and the left ventriculogram will be recorded for comparison with volumes measured
i.
t
echocardiographically. Definition of the strengths and limitations of this technique
in the controlled environment of the catherization laboratory will allow use of
this procedure in patients undergoing studies involving the .administration of
cardiac drugs. Since invasive techniques have severe limitations for developing
a25	 -
t
r
ventricular function curves in man, it is significant that these clinical trials
will offer a totally non-invasive technique for determining cardiac pump dynamics.
Besides the above proposed cath lab studies with a leg negative pressure
unit, it appears that this unit will be applicable to other areas of medical
investigation. Nephrologists at Stanford Medical School are interested in the
renal (kidney) regulation of blood pressure and another group of investigators 	 1
is studying the responses of the carotid and aortic bodies to hypertension.
The LNP unit could provide a non-invasive orthostatic stress for investigating
x
the physiological mechanisms involved in these studies.
PERSONNEL
Principal Investigators:	 Richard Popp, M.D., Assistant Professor
of Cardiology
Edwin Alderman, M.D., Assistant Professor
or Cardiology
BATeam Coordinator	 Gene Schmidt, M.D.
i	 Cardiology Fellow	 Randolph Martin, MD.
Engineering Technician	 Cecil Profitt
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INTP,ACRANIAL PRESSURE MONITORING
OBJECTIVES:
1. To develop a reliable system for the continuous, long-term
	 -
monitoring of intracranial pressure.
2. To involve commercial manufacturing companies in this development
so that the final model of this device can be manufactured and
marketed for use in any hospital.
BACKGROUND:
i
The human brain is surrounded by a constantly circulating clear liquid
called cerebro spinal fluid or CSF. If the brain suffers a severe insult
(either from a blow to the head, infection, or tumor), the fluid pressure
("intracranial pressure", or "ICP") increases. The ICP may also rise during
recovery from brain surgery and in children with hydrocephalus. Over 100,000 	 I
patients in the U.S. each year suffer from diseases or trauma which cause a
dangerous increase in intracranial pressure. If the ICP increases excessively,
the brain suffers irreversible damage. Medical and surgical techniques capable
of controlling ICP are available; however,	 techniques for measuring this vital
	 !i
parameter are still not perfected. A system which could continuously and
accurately measure ICP over a long period of time -- with minima l
 patient risk
-- would have great clinical impact and would improve patient care considerably.
Under a NASA Biological Applications Team grant, the Stanford University
School of Medicine and the NASA-Ames Research Center are working cooperatively
to produce such a system. They have started with an Ames-developed pressure
transducer carrying its own on-board electronics and antenna for telemetering
the measured pressure.
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Earlier this year, bench tests and pressure stability trials on several
types of pressure transducers had established that the type having the lowest
drift and hysteresis in a capacitative transducer which had been developed
at the Ames Research Center for measuring air pressure changes during wind
tunnel tests (See Figure 1.).
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Fig. *i.
NASA-Ames pressure cell originally
developed for wind tunnel aeronautical
testing.
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Although the Ames transducer diaphragm is made of 48% nickle-iron
steel, a material	 highly susceptible to corrosion by body fluids, it can
be rendered non-reactive by coating it with parylene (Union Carbide Co.).
Two transducers so coated, each having its requisite electronics
	 (LC oscillator)
l^
but lacking the telemetry component, were furnished to the Stanford Medical
School	 team for implantation trials.
	 For these preliminary trials, a coaxial
cable was used to deliver activating power to bring out the pressure signal
-< (about 9 MHz).
PROCEDURE
The transducer is mounted through a small	 burr hole drilled through the
With	 its
	 diaphragmskull.	 sensitive	 lightly touching the outer lining (dura)
of the brain; the scalp is then closed over the unit, and ICP readings taken
b	 the transducer are telemetered to
	 ny	 a receiving a tenna located near the
head.	 In this way, wires penetrating an open scalp incision, with the probable
chance of infection, 	 are eliminated
	 (see Figure 2.).
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PROGRESS
Work completed this year was in five major areas:
1. Performing long-term in vitro temperature and pressure cycling
tests to determine baseline drift.
2. Doing chronic animal implant actions to perfect the surgical
technique and detect tissue reaction to the materials used.
3. Presenting-papersat scientific meetings to inform colleagues of
progress in engineering and surgical aspects of these studies
(Refs 7, 8).
4. Interacting with a commercial manufacturer regarding specification
and improvements in the original design. Four meetings between
the Stanford Team and the commercial manufacturer took place.
5. Obtaining support for data processing equipment necessary to the
performance of initial studies in human subjects.
Drift rate and compatibility in vivo were observed by implanting two
cable-connected transducers in dogs. The cables were placed entirely under
the scalp, after each system was checked for calibration against a manometer
connected to a needle in the cisterna magna. Then the end of the cable was
sealed and tucked beneath the skin. When system checks were later desired,
this connector was extricated throu gh a small incision in the scalp. Tissue
examination revealed no evidence of swelling, edema, or vascularization in
the dura directly under the transducer in either dog. This suggests that a
titanium transducer with completely sealed telemetry electronics should be
suitable for future long-term implantations. In addition, two Ames transducers
30
having the completed telemetry electronics package, undergoing in-vitro
(370
 C. water bath) testing showed considerable drift (2 to 3 Torr/day)
initially, and so were not considered for implant tests. Their drift rate,
however, shows signs of slowing down, and these two may yet be usable for
experimental purposes.
Six improved models of the transducers with on-board telemetry packages
were ordered by the Ames Research Center, at the beginning of this year. Delivery
of these units from the Konigsberg Instrument Company, Pasadena, California, is
set for November, 1976. In this model, the transducer, including the 0.003-inch-thick
diaphragm, is machined from titanium. The electronics package has been improved and
further miniaturized. Also, a single antenna, rather than the original pair of
antennas, is used. Non-welded seams are sealed with an epoxy compatible with
body fluids.
PLANS
A new Ph.D bioengineer will join our BATeam on a part-time basis to
assist with setting up and operating the electronic data recording equipment to
be ordered for clinical studies. He will be responsible for transducer
calibration and bench testing. Emphasis will be placed on evaluating Konisberg
transducer-telemetry units which are to be delivered this fall. The six improved
"	 units will begin a series of rigorous laboratory tests (in-vitro, acute implanta-
tion, and chronic implantation in animals). If this improved system proves to
be stable, clinical tests will begin during 1977.
A calculator-based set of monitoring equipment designed to record,
correlate, and present the ICP and associated parameters (e.g., heart rate, end-
`"	 expired carbon dioxide, mean arterial pressure) will be ordered. Together
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with equipment already on loan from the School of Medicine and the Ames-
Research Center, a sophisticated data handling system will be assembled.
This equipment allows gathering high quality of data needed to gain acceptance
for this introcranial pressure monitoring system by the medical profession.
PERSONNEL:
Principle Investigators: 	 Gerald Silverberg, M.D., Assistant Professor
Neurosurgery at Stanford Medical School
Allen Ream, M.D., Assistant Professor of
Anesthesiology, Stanford Medical School
BATeam Coordinator: 	 Robert J. Debs
NASA Engineer:	 Thomas Fryer, Assistant Chief of Electronics.
Instrument Development Branch
r	 !	 'i	 I	 1
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COMMERCIALIZATION ACTIVITIES SUMMARY
INTRODUCTION
The overall goal of the NASA Technology Utilization Program is to insure
the widest possible dissemination and utilization of technology developed
through the aerospace program. An important way in which technology can
reach a large number of users is through the manufacturing, marketing and
distributing capabilities of private industry. If there appears to be a
widespread need within the medical profession for a device based on NASA
technology, the Biomedical Applications Teams contact medical instrument
manufacturers to determine the feasibility of commercialization. The medical
device manufacturing industry is extremely competitive and for each idea which
leads to a successful product line, there are hundreds which prove to be com-
mercially , unfeasible. One can therefore expect that only a small percentage
of proposed technological solutions can ever achieve successful large scale
commercialization. However, if the biomedical problems are originated by
reliable medical investigators, and the problems are screened for their potential
to satisfy a significant need in the medical profession, the liklihood of re-
alizing a commerrializable NASA technological solution is increased.
This year the Stanford Biomedical Applications Team has established
numerous relationships with medical device manufacturers. The most successful
commercialization activities are listed below followed by a brief summary of
the present commercialization status._ Greater detail on each of these pro-
{	 j ects is provided in the remainder of this section.
{	 1. Flexible Medical Electrodes - These have been commercially available
since January, 1975 through the In Vivo Mertric Systems, Redwood Valley,
!	 California, and the manufaturer has already made improvements that were
I	 'i	 I . I	 I
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suggested by the Stanford Biomedical Applications Team. In May, 1976 the
manufacturer issued a new product bulletin describing these flexible surface
electrodes as a development of NASA technology.
2. NASA Echocardioscope - A commercial product development program is
under way involving the Rohe Scientific Corporation. NASA funding to share
research and development costs for this commercialization project has been
granted. The first of a family of Echocardioscopes based on ultrasound work
at the NASA-Ames Research Center are to be delivered in January, 1977.
3. Miniature Biolemetry System - A miniature Biolemetry System designed
at the Ames-Research Center for use in the evaluation of children with cerebral
palsy has been fabricated and delivered to the Children's Hospital at Stanford.
The manufacturer is awaiting clinical validation of this unique system before
proceeding with further production.
4. Neurosurgical Pressure - Telemetry System - Konigsberg Instrument
Corporation is completing work on a capacitive intracranial pressure transducer
complete with telemetry electronics. Delivery of the first units is 'expected
in November, 1976. The company has designed this monitoring system to facilitate
mass production. A program of laboratory validation at Stanford University
Medical School will begin this fall.
5, On-Line Ventricular Contour Detector -- Four medical device manufacturers
have requested information on this device as a result of the NASA Biomedical'
Applications Conference held at the University of Conn. Health Center, September
21, 1976. Detailed technical reports have been supplied to them and we anticipate
further collaboration.
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FLEXIBLE MEDICAL ELECTRODES
PROBLEM DEFINITION
A medical electrode is a device *for monitoring physiological signals.
It is usually made of a highly conductive metallic compound which permits the
passage of electrical signals from the patient to a recording instrument with
minimal signal loss. The largest single use of medicle electrodes is in
cardiology for monitoring the electrocardiogram. Applications of medical
electrodes include recording brain waves, respiratory activity, and monitoring
muscle contraction as previously described in this report (EMG Telemetry in
Cerebral Palsy).
While electrodes at first appear to be rather simple devices, lack of
understanding of the electrochemical process which takes place at the junction
between the skin surface and the metallic surface of the electrode, has lead
to difficult problems, particularly in long-term monitoring. Millions of
dollars have been spent by industry in developing sophisticated amplification
and filtering devices to process the signal derived from the electrode.
However, inadequate attention has been focused on the electrode itself, the
primary link in the chain of monitoring equipment.
BACKGROUND
NASA has had extensive experience in the development and use of electrodes
to monitor physiological signals from astronauts both during space flight and
during long-term bed rest studies in space simulation exercises. In 1973,
NASA sponsored an international conference entitled "Biomedical Electrode
Technology - Theory and Practice". This conference was held at Stanford
University and conducted by the Stanford Biomedical Applications Team.
i u
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Through efforts of the BATeam, the proceedings of this conference was
published in a reference text, Biomedical Electrode Technology - Theory and
Practice, edited by Donald C. Harrison, M.D. and Harry Miller. This text is
now in its third publicatioi ► and over a thousand copies have been sold.
COMMERCIALIZATION
'Through these efforts by the Stanford Biomedical Applications Team to
disseminate NASA technology, biomedical electrodes based on a NASA design have
been commercialized. Recently the In Vivo Metric Systems Company, Redwood
Valley, California, has made improvements to its new line of flexible skin
electrodes (see excerpt of their product bulletin below). Thesa electrodes
are based on work with flexible conductive materials at the NASA-Ames Research
Center.
Flexible Skin Electrodes
IVM flexible skin electrodes were developed by NASA technology. Because they are
soft and easily conform to the body surface, these electrodes allow long-term monitor-
ing without patient discomfort.
The sensor of each electrode is constructed of elasticized nylon mesh impregnated with
silver and chlorided for better signal quality. Resistivity is stable at 1 ohm per square.
The cable is securely attached to the electrode with silver-loaded epoxy.
Flexible electrodes may be used dry; however, E404 electrode gel or E407 gel-impreg-
nated pads will improve signal quality. Electrodes are easily attached to the patient with
surgical tape, bandages, or adhesive discs (E402). Note: Adhesive discs should be used
only if the electrode is used once. All electrodes are supplied without termination pin.
E213
	
s ~	 ,^ Diameter:	 20 mmx
	
lene foam.Padding:	 1.5 mm-dhick closed-cell polyethylP Y Y
	Cable:	 1 meter, vinyl insulated wire
E217 Diameter: 20 mm
Padding: 6 mm-thick open-cell foam rubber
A Cable: 1 meter, silicon rubber insulated wire
i	
>
Note: The wire and rim of the electrode are sealed to the
padding with silicone rubber. Use of silicone rubber
makes the electrode washab le and reusable.
E21 R Diameter: 20 mm
Padding: None provided.
Cable: 1 meter, vinyl insulated wire
Note: E218 electrodes are available at low cost and well
suited for one-time use.
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Hayes Products Inc., Seattle, Washington, has also worked with the
Stanford BATeam on an improved design of this type of electrode. During this
reporting period we offered some suggestions for design improvements.
Also during this year we have provided relevant NASA technical literature
on electrodes to Life Technical Instruments, Houston, Texas, and Physio-Control
Corporation, Seattle, Washington. 14e plan to continue to interact with medical
device manufacturers and provide them with information on NASA technology in
the field of biomedical electrodes.
Ya...	 a
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NASA Echocardioscope
BACKGROUND
An echocardioscope is a device for imaging the heart non-invasively
using sound energy. High frequency sound waves are emitted from a transducer
and conducted through the chest where they impinge upon the heart (see fig.l
below). Various structures within the heart reflect these pulses of sound
energy. The echos are received, processed and displayed to form an image
which can be interpreted by the cardiologis'
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Top-NASA-developed echocardioscope being used
to examine a patient. Below right - ultra-
sonic beam is directed at different heart struc-
tures. Below left - changes in echo patters as
different structures are visualized.
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NASA TECHNOLOGY {
NASA engineers have been develo ping echocardios copes for several years..
The most recent NASA contributions to this field have been published in the
reference text, Cardiovascular Imaging and Image Processing - Theory and
	 -^
Practice, 1975 edited by Donalc C. Harrison, Harold Sandler, and Harry Miller.
The specific echocardioscope depicted (Fig. 1) is one of a series of prototypes
being developed for use in conjunction with the Space Shuttle program.
COMMERCIALIZATION PROGRESS
During this reporting period, the Stanford Biomedical Applications Team
met with leading manufacturers of ultrasound equipment in the Un1-11-ed States.
Representatives of the Rohe Scientific Instrument Company, Pasadena, California,
agreed to begin preliminary engineering redesign of the portable batter-powered
echocardioscope originally intended for use in space. Their goal is to develop
a moderately priced single transducer instrument for use in hospitals and
clinics. Their engineering staff is making modifications to update the
electronics in this device, incorporate integrated circuitry and make it
modular for easy serviceability. Commercialization plans call for developing
a family of echocardioscopes. The first production prototypes are to be com-
pleted by January, 1977; to be followed shortly thereafter by a more advanced
m
array device, capable of two dimensional imaging based on theNASA-Ames 3E
Ultrasonoscope shown in figure 2. Rohe has applied fora non-exclusive
license to.manufacture this instrument.
t
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Fig. 2
NASA-Ames Research Center 3E Ultra-
sonoscope with both single trans-
ducer and linear array transducer.
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Funding to allow cost sharing of the additional design work needed
to make the NASA instrument commercially feasible has been granted. A
contract between the Stanford Biomedical Application Team and the Rohe
Ccmpany has been formulated. Signing of this contract has been delayed
pending approval of a merger of Rohe Scientific_ with North American
Phillips Corporation. We anticipate that our commercialization plan
with Rohe will proceed on schedule once the proposed merger is approved
by the Federal Trade Commission
40
MINIATURE BIOTELEMETRY SYSTEM
k
NASA technology, and implementation of this project has been previously
described under the heading (EMG Telemetry and Cerebral Palsy). The bio-
telemetry system developed for this project required the close interaction
between members of the BATeam, NASA-Ames Research Center, and the L&M Electronics
Corporation. During this reporting period numerous meetings were held with
the manufacturer to determine specifications, make electronic component selections,
and determine packaging requirements. Human factor engineering considerations
included the following:
1. The transmission equipment had to be easily applied to and removed
from the child.
2. Use of the equipment in the clinical laboratory was to require a
minimal understanding of RF telemetry.
3. The transmitter had to be rugged to withstand falls and rough
handling by children.
I
4. The transmitter should be disguised to increased their acceptance
by very young pediatric patients.
PLANS
a
Further production of this biotelemetry system has been discussed with i
the manufacturer. Future .orders for this device will be accepted only after
thorough clinical trials have been completed, thus allowing ideas for improve-
ments based on these trials. Possible improvements could include reducing the
transmitter electronics to a single intergrated circuit chip (thus reducing
the size of the transmitter by half) and utilizing a simpler FM-FM telemetry
approach. Once clinical trials with the pre-production prototype are satis
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factorily completed at Stanford Children's Hospital this system will be
offered to the other gait laboratories in the United States which are listed
in the registry compiled. .by the Committee on Prosthetics Research and
Development of the National Academy of Sciences. Use of this miniature bio-
telemetry system is not limited to monitoring the EMG. It can also be used
for telemetering other physiological signals such as the electrocardiogram,
body temperature, blood pressure, etc.
INTRACRANIAL PRESSURE MONITORING SYSTEM
The Konigsberg Instrument Inc, Pasadena, California, is now fabricating
pre-production prototype intracranial pressure transducers with accessory
telemetry electronics, The transducer design has gone through four inter-
actions with emphasis placed on achieving a production line model. The as-
sociated electronics for telemetering the intracranial pressure signal has been
made compatible with secondary transmission via a crystal-controlled FM trans-
mission at 88 MHz. As in the previous commercialization project, production of
additional units must await rigorous laboratory and animal validation studies.
Satisfaction completion of these preliminary tests will be followed by clinical
trials in neurosurgical patients at Stanford University and Santa Clara Valley
Medical Centers. Although this is an implantable device, it can be used in
research applications without pre-market clearance under provisions of the new
medical device legislation. The manufacturer is aware of medical device clear-
ance procedures and is planning to file-for approval by the appropriate FDA
standards planel.
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ON-LINE VENTRICULAR CONTOUR DETECTOR
PROBLEM DEFINITION
During the analysis of X-ray motion pictures of the heart, the i
calculation of various anatomic quantities is based on measurements which rx
are presently made by hand.	 Because calculations based on these measurements x
lead cardiologists to a specific diagnosis and recommendation for either
medical treatment or surgery, the accuracy and repeatability of these manual
'
measurements is important. 	 To reduce the human error and time involved in this
F
process, on-line computerized methods are being developed by NASA for rapidly
detecting	 and analyzing X-ray images of the heart (Ref. 9)..
RELEVANT NASA EXPERTISE
Analog and digital computer-graphic methods have been developed at
the NASA-Ames Research Center for analysis of X-ray images of the heart.
These techniques have been developed to analyse X-ray.s of laboratory animals
taken during stress testing before, during and after simulated space flights.
APPROACH
A significant portion of the anatomy of the heart that is revealed during
X-ray studies is the outline or contour of the left ventricle, the main pumping
4
chamber of the heart.	 The size, shape, and movement of the walls of the heart
are directly related to the ability of the heart to function as an efficient
pump.	 To make the outline or contour of the heart visible to X-rays a special
dye is first injected into the ventricle.
	 As this dye is pumped out of the
heart, X-ray motion pictures are taken.	 These are recorded both by video and
cine techniques.	 An image of the ventricle can be displayed on a video monitor
1l
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as shown in the figure below. With the use of a computer this image is scanned
and multiple white line contours or outlines are rapidly and automatically
drawn (see figure).
^.t.
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Computer Drawn Ventricular Outlines of X-ray Image of Human Heart.
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The coordinates of this outline are stored in the computer's memory. These
coordinates are used to make a printed tracing of the image and to perform
a large number of calculations which tell the heart specialist such important
information as the size of the heart, the amount of blood ejected with each
beat, and the amount of contraction taking place in different portions of the
heart. This working system has been shown to be accurate within two percent
when predicting the volume of plastic casts of hearts for which the exact
L'
r
volume is known.
STATUS
A team from Stanford consisting of cardiologists, a computE
a computer hardware engineer, a biomedical engineer have reviewed and evaluated
this automated ventricular contour detection system. At present, it is not
ready for direct transfer to the hospital for use in patients. Proposals to
continue to refine this system utilizing the image processing expertise of
scientists at the Jet Propulsion Laboratory, Pasadena, California, are in
preparation.
This system was described to a group of New England Company representatives
at the University of Connecticut Health Center in September, 1976. Four
corporations requesting additional information were:
Instrumentation Laboratory Inc., Lexington,.Massachusetts
PARA Company, West Hartford, Connecticut
New England Nuclear, North Billerica, Massachusetts
Electronic Associates Inc., Wilone Branch, New Jersey.
Reprints from the Cardiovascular Imaging and Image Processing Conference
and NASA Technical Reports describing this sytem were subsequently sent to
these companies.
r	 ^	 '	 1	 1	 1	 1
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PUBLIC INFORMATION ACTIVITIES
One of the functions of the Biomedical Applications Teams is to inform
the scientific community and general public of NASA technological developments
and capabilities which are being applied to solving medical problems. In order
to disseminate scientific information and increase public awareness of NASA
biomedical activities, the Stanford team has completed two major projects
during this past year. The first was the publication of the proceedings of
the Third International Symposium On Biotelemetry, and the second has been
the completion of the motion picture, "Dividends From Space", which illustrates
the functions of the Biomedical Applications Team program.
F BIOTELEMETRY III
k	 The proceedings of the NASA-sponsored Third International Symposium on
Biotelemetry have been edited into a reference text entitled,Biotelemetry III,
i
and representing the work of 82 contributors. The editors are Thomas Fryer
and Harold Sandler. M.D. both from the NASA-Ames Research Center and Harry
f	 Miller, Paul Purser, and Manley Hood, members of the Stanford Biomedical
Applications Team. Copies of this 400 page text may be purchased through the
Ordering Department, Academic Press, Inc., 11 5th Ave, New York, 1003. It
will sell for approximately $25,00 in hardback form, available in December, 1976.
f
DIVIDENDS FROM SPACE
During this reporting period, the twenty-two minute, color motion picture,
"Dividends From Space - Biomediical Applications of Aerospace Technology" has
been completed and the first four prints delivered. This film uses examples of
successful transfers of NASA Technology in such diverse areas of medicine as
Pediatrics, Cardiology and Neurosurgery. The film was produced in cooperation
with Film Media, Incorporated, Santa Clara, California. This film is intended
for use at engineering and medical meetings, community meetings, by television
networks, and in academic training programs. An abstract of the film follows:
The spectacular accomplishments of the
Manned Space Program have made NASA a household
word. Less appreciated is the fact that NASA has
established a Technology Utilization Program to
insure that advances in aerospace technology are	 -^
reapplied to the solution of industrial, social,
and medical problems. This 20 minute color film
illustrates the philosophy and function of the
Biomedical Applications Team within NASA'S
Technology Utilization Program. Each of the
four regional Biomedical Applications Teams
has a particular area of emphasis. The Stanford
Team operates within the Cardiology Division of the
Stanford University School of Medicine and is
monitored by the NASA-Ames Research Center.
Emphasis is placed on adaptation of aerospace
instrumentation to the diagnosis and treatment
of heart disease. Projects illustrating its
scope of activities are: 1) an on-line, com-
puterized, ventricular outline analyzer, 2) an
	 .
implantable, miniaturized, intracranial pressure
telemetry system, 3) a portable, battery-powered, 	 j
ultrasonic echocardioscope, 4) an ultra-flexible
biomedical electrode, 5) an electromyographic
telemetry system for the gait analysis 'of
crippled children. These approaches to solving
medical problems require the close cooperation
of engineers, physicians, nurses, physical
therapists, and electronics technicians who
pool their talents in an effort to utilize
advanced technology to improve the quality of
patient care.
This film has been accepted for showing at the San Diego Biomedical
Symposium in February, 1977 and also the Twelfth Annual Meeting of the
Association for the Advancement of Medical Instrumentation (AAMI) in March,
1977. The Stanford BATeam will work with the NASA Office of Public Affairs
to obtain additional copies of the film and schedule nation wide showings.
9
f ?
r
f
NEW MEDICAL PROBLEM AREAS
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NEW BIOMEDICAL PROBLEM AREAS
IF
CEREBRAL PALSY COMMUNICATION DEVICE
To provide a synthetic speech device for use by non-vocal cerebral palsied
children.
BACKGROUND
There is a large number of people who cannot speak and who have inadequate
use of their hands and arms eliminating other forms of non-verbal communication
such as writing and sign language. This group of patients includes those with
spinal cord injuries, head injuries, stroke and patients with cerebral palsy.
Patients with cerebral palsy frequently have normal intelligence but lack
proper coordination of the muscles involved in speaking, writing and walking.
The degree of motor impairment in cerebral palsy varies greatly from patient
to patient.	 A communication system for such patients would therefore need
to have an adaptable interface which is tailored to the capabilities of each
patient.
NASA TECHNOLOGY
Within the Man Machine Integration Branch at the NASA-Ames Research Center,
a team of engineers (computer programmers, and a voice research specialist) are
working on the problem of man-machine voice communications. They are developing
programs and hardware for both speech recognition and speech synthesis.
Their work is in flight management systems in which speech input is used
by pilots to issue aircraft control commands, thus reducing the number of switches
and controls which must presently be activated manually. They are evaluating
speech input as a way of reducing the complexity of the pilot's task and increasing
48
his efficiency, particularly in advanced aircraft such as the vertical take-
off and lander (VTOL). They are also developing a speech synthesizing system
which would give the pilot verbal information regarding such flight parameters
as altitude and engine thrust during critical phases of landing, while the -
pilot's eyes must be fixed on the runway. NASA-Ames investigators are enthusi-
astic about the possibility of using the speech recognition and synthesis systems
as communications aids for the speech-impaired patient.
n r)r%n1 rAA CT RTIIC .
This problem is still in the exploratory and discussion phase. In addition
to meetings at the Stanford Children's Hospital and the NASA-Ames Research
Center, we have discussed this p; •oblem with biomedical engineers at the Research
Triangle Institute BATeam. RTI has begun simular discussions with rehabili-
tation centers on the east coast, including the United Cerebral Palsy Associ-
ation of Nassau County, The Bernard Fineson Developmental Center, and the
Gifted Handicapped Center at the University of North Carolina. We intend to
coordinate our activities with the RTI BATeam in identifying NASA technology
applicable to this problem.
r	 I	 I	 'i
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LIQUID COOLED GARMENT APPLICATIONS
OBJECTIVES	 -
To evaluate a NASA-developed liquid cooled garment in both research and
patient care applications at the Stanford University Medical Center.
nnrvr_Dntmin
There is a need for better methods of lowering the body temperature of
patients being treated for a variety of medical problems.
1. Hypothermia is gaining increasing acceptance in the
specialty of cardiovascular surgery. Because lowering
the body temperature decreases matabolic rate and oxygen
consumption, hypothermia has become an accepted alternative
to cardiopulmonary bypass in the performance of open heart
surgery on infants.
2. Surface cooling is being used prior to cardiopulmonary bypass
(using the heart-lung machine) to allow reaching low body
temperatures more rapidly.
3. Lowering body temperature has been shown to have a protective
effect on patients with elevated intracranial pressure and
further research is being done in this area.
4. Better methods of controlling fever are needed fin patients with
infection or who have brain injury. Presently available cooling
blankets are inadequate for these problems.. They do not provide
close enough contact with a large enough body surface area to
achieve the desired level of cooling. In addition it is difficult
to regulate the temperature of these cooling blankets with the
desired degree of control.
NASA TECHNOLOGY
Liquid cooling garments (LCG) have been developed within the space
program to protect astronauts from adverse thermal conditions during extra vehicular
activity. Investigators at the NASA-Ames Research Center have made improvements
f	 on the original LCG's used during the Appollo missions. These new garments utilize
r i
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a flexible polymer that has thousands of tiny channels inscribed in it through
which cold water is circulated. Close contact with the body surface is main-
tained by incorporating cooling panels made from this material inside an elastic
suit made of spandex.
PROJECT STATUS
1
Ames Research Center physiologist and engineers have met with doctors at
the Stanford University Medical School in the Departments of Neurosurgery and
Anesthesiology to specify requirements for a liquid cooled garment to be used in
the four areas listed above. They have agreed upon a design which allows con-
tinuous cooling of the patient without interferring with the routine nursing
care. The loan of a liquid cooled garment and its attendant refrigeration
unit is anticipated during December, 1976.
PERSONNEL
Gerald Silverberg, M.D.
Stanford University
Medical School
Gene Schmidt, M.D.
BATeam Coordinator
Allen Ream, M.D.
Stanford University
Medical School
Bill Williams
NASA-Ames Research Center
Bruce Webbon
NASA-Ames Research
Center
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MINIATURE CARDIAC FORCE TRANSDUCER
Objective:. To utilize NASA developed miniature cardiac force
transducers to investigate the effects of myocardial ischemia in laboratory
animals.
Background: One very important research area in Cardiology is determining
the effects of coronary artery occlusion on the contractility of heart muscle.
Knowing how heart muscle is affected by the sudden loss of blood flow through
the coronary arteries has direct bearing on the outcome of heart attack victims.
NASA Technology: Several designs for miniature transducers which would
be applicable to cardiac research have been developed at the Jet Propulsion
Laboratory (JPL) under NASA sponsorship. JPL scientists R.H. $ilv^^
	 '' ' ^ ^^
C. Feldstein, E. N. Durand, and J. C. Fletcher have been issued a
transducer depicted in the drawing below.
Strain (
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The miniature transducers would be one cm across and have tines from
seven to eleven mm in length. As shown in the figure the tines would have barbs
to secure them into the heart muscle and wires running from the transducing_
element would provide a measurement of contractile force.
Proposed Application: The Stanford University Division of Cardiology has
an NIH funded Program Project Grant entitled "Pharmacologic and Physiologic
Basis of Cardiac Therapy". As part of this program in investigating new
modalities for treatment of heart disease, Stanford researchers are studying
the effects of artificially produced ischemia in laboratory animals. Speci-
fically, the work calls for the recording of both myocardial contractile force
and regional "cardial electrogram" in open chested dogs during acute coronary
artery ligation. An array of six contractile transducers serving the double
purpose of providing a localized ECG signal would be used to inap the "zone of
ischemia" produced by sudden interruption of the blood flow through the coronary
arteries.
Problem Status: The Jet Propulsion Laboratory has submitted a proposal
to NASA to make improvements upon an earlier design for the miniature force
transducer. Approval of this proposal would allow the Stanford Biomedical
Applications Team to work with Jet Propulsion Laboratory scientists in
applying these miniature transducers to this very important area of Cardiology
pharmacological research.
Transducers furnished by JPL would be used to study the effect of
accepted and investigational pharmacological agents used in the treatment of
heart patients. How these cardiac drugs affect contractile force and the size
of the heart muscles are important medical questions to be answered if one is
to develop a rational basis for treating heart attack patients.
J
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Time Schedule: Implementing these force transducers in the animal
research laboratories at Stanford is dependent upon funding of the JPL proposal
to develop these transducers. The need at Stanford is for six of these units
with their appropriate signal conditioning electonics for implantation in open
chested dogs. The planned experiments with the transducers will be scheduled
so that all studies can be completed within three months of receipt of the
required units from JPL.
r1.
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APPENDIX A - PUBLICATIONS RESULTING FROM B.A.TEAM PROJE
Bleck, E. E., Ford, F.: Electromyographic Telemetry Analysi!
Patterns in Normal and Spastic Cerebral Palsied Children with Special
Reference to the Quadriceps and Hamstring Muscles. Read at the November,
1974 meeting of the American Academy for Cerebral Palsy in Denver,
Colorado. Submitted for publication to Journal of Developmental Medicine
and Child Neurology.
Ford, F., Bleck, E. E., Collins, F. J.: The Effects of Dantrolene
Sodium on the Gait and Motor Function of Children with Spastic Cerebral
Paralysis - Objective Measurements Compared with Subjective Responses;
submitteu to Journal of Developmental Medicine and Child Neurology.
Ford, F., Rositano, S., Schmidt, E. V.: Clinical Pediatric Gait Biotelemetry,
Biotelemetr.y . III, Proceedings of the Third International S_ymposiumon
Biotelemetr	 May 17 - 20, 1976, Academic Press, New York. (In Press).
4. Westbrook, R. M., Fryer, T. B., Rositano, S. A.: A Wideband'EMG Telemetry
System. Ibid.
5. Schmidt, E. V., Debusk, R. F., Popp, R. L.: Proposed Applications of lower
body negative pressure to cardiology. Proceedings of the Eighth Conference
on Space Simulation, November 3 - 5, 1975, NASA SP-379.
6. Schmidt, E. V., Debusk, R. F., Popp, R. L.: Appl i cati ons of lower body
negative pressure testing to cardiology. AAMI Journal, (abstract)
Cardiovascular Hemodynamics Section, Harch 22, 1976.
7. Fryer, T. B.: A Pressure Telemetry System Utilizing a Capacity Type Transducer.
Proceedings of the Third International Symposium on Biotelemetry, May 17 - 20,
1976, Academic Press, New York. (In Press).
8. Silverberg, G. D., Ream, A. K., et al: Intracranial Pressure Monitoring
using Implanted Epidermal Capacitance Transducer and Telemetry. Ibid.
9. Reiber, J. A.; Real Time Detection and Data Acquisition for the Left
Ventricular Outline, NASA Technical Report, NASA TR R-461, June, 1976.
;_
__
	
1 e
APPENDIX B - MEDICAL DEVICE MANUFACTURES
Below is a list of Medical Device Companies that are workinc
Stanford BATeam on the Commercialization of technology derived 1
research and development.
In Vivo Metric Systems
P. 0. Box 217
Redwood Valley s California 95470
Konigsberg Instruments, Inc.
2000 East Foothill Blvd.
Pasadena, California 91107
L & M Electronics Company
2401 Geneva Avenue
Daly City, California 94014
Rohe Scientific Corporation
2158 South Hathaway Street
P. 0. Box 10760
Santa Ana, California 92711
